Who has invested in PDC*line Pharma?

Korea Investment Partners, LG Chem are named among the investors backing PDC*line Pharma.

PDC*line Pharma Funding: $68M Raised, Series B (2021)

PDC*line Pharma funding overview

PDC*line Pharma is based in Liège, Belgium. PDC*line Pharma has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2021. The round record for PDC*line Pharma runs through 2021; nothing later has been disclosed. Investors on record include Korea Investment Partners, LG Chem. 2 distinct backers are named across the disclosed rounds.

PDC*line Pharma at a glance

Total raised: $68M
Latest round: Series B
Latest round date: November 2021
Headquarters: Liège, Belgium
Notable investors: Korea Investment Partners, LG Chem

Frequently asked about PDC*line Pharma funding

How much has PDC*line Pharma raised?: PDC*line Pharma has raised $68M in total disclosed funding across the rounds on record.
Who has invested in PDC*line Pharma?: Korea Investment Partners, LG Chem are named among the investors backing PDC*line Pharma.
What was the latest PDC*line Pharma funding round?: The most recent disclosed round is a Series B, announced in November 2021.
Where is PDC*line Pharma based?: PDC*line Pharma is based in Liège, Belgium.
When did PDC*line Pharma last raise?: The last disclosed PDC*line Pharma round closed in November 2021 at Series B.

Every PDC*line Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Liège at a similar stage.

PDC*line Pharma Funding: $68M Raised, Series B (2021)

PDC*line Pharma funding overview

PDC*line Pharma at a glance

Frequently asked about PDC*line Pharma funding

Companies related to PDC*line Pharma (20)

Browse related funding lists (4)